Biosimilars: A Strategic Opportunity for Pharma Executives
The Market Potential of Biosimilars The global biosimilars market is experiencing exponential growth. In 2023, it was valued at approximately $30 billion and is projected to reach $60 billion by 2028. This growth is driven by the expiration of patents for blockbuster biologics, increasing healthcare costs, and rising demand for affordable treatment options. Key Market … Continue reading Biosimilars: A Strategic Opportunity for Pharma Executives
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed